Quarterly Report • Oct 5, 2015
Quarterly Report
Open in ViewerOpens in native device viewer
REG. No 8649 / 06 / Β / 86 / 45
HEAD OFFICE: OLΥMPOU 32 - 57009 - KALOHORI - THESSALONIKI
| BALANCE SHEET (consolidated and stand alone) amounts in thousand Euros | STATEMENT OF CHANGES IN EQUITY (consolidated and stand alone) amounts in thousand Euros | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| GROUP | COMPANY | GROUP | COMPANY | ||||||
| 30.06.2007 | 31.12.2006 | 30.06.2007 | 31.12.2006 | 30.06.2007 | 30.06.2006 | 30.06.2007 | 30.06.2006 | ||
| 72.787 | 68.071 | 25.768 | 25.464 | (01.01.2007 and 01.01.2006 respectively) | 77.288 | 68.476 | 63.519 | 63.713 | |
| Investments in subsidiaries, associates and other companies | 1.177 | 4.134 | 26.611 | 25.416 | Profit / (loss) for the period, after taxes | 1.384 | 1.461 | 938 | 649 |
| 22.535 | 24.166 | 7.236 | 9.675 | Total | 78.672 | 69.937 | 64.457 | 64.362 | |
| 62.474 | 70.906 | 35.519 | 42.678 | Increase / (decrease) in share capital of subsidiaries | 0 | 370 | 0 | 0 | |
| 20.183 | 20.176 | 3.785 | 8.341 | Dividends of parent company | (958) | (958) | (958) | (958) | |
| 179.156 | 187.453 | 98.919 | 111.574 | Dividends paid to Minority Interests | 0 | (113) | 0 | 0 | |
| Net gains and losses recognised directly in equity | 1.873 | 154 | 0 | 0 | |||||
| 24.753 | 16.469 | 603 | 2.614 | of available for sale financial assets | (1.192) | 0 | (1.192) | 0 | |
| 33.009 | 37.905 | 11.360 | 6.495 | Increase in the percentage of ownership in subsidiaries | 411 | 0 | 0 | 0 | |
| 42.588 | 55.791 | 24.649 | 38.946 | (Purchases) / sales of treasury shares | 0 | (139) | 0 | (139) | |
| 51.287 | 51.287 | 51.287 | 51.287 | (30.06.2007 and 30.06.2006 respectively) | 78.806 | 69.251 | 62.307 | 63.265 | |
| GROUP | COMPANY | GROUP | COMPANY | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 30.06.2007 | 31.12.2006 | 30.06.2007 | 31.12.2006 | 30.06.2007 | 30.06.2006 | 30.06.2007 | 30.06.2006 | ||
| ASSETS | Equity at the beginning of the period | ||||||||
| Tangible and intangible assets | 72.787 | 68.071 | 25.768 | 25.464 | (01.01.2007 and 01.01.2006 respectively) | 77.288 | 68.476 | 63.519 | 63.713 |
| Investments in subsidiaries, associates and other companies | 1.177 | 4.134 | 26.611 | 25.416 | Profit / (loss) for the period, after taxes | 1.384 | 1.461 | 938 | 649 |
| Inventories | 22.535 | 24.166 | 7.236 | 9.675 | Total | 78.672 | 69.937 | 64.457 | 64.362 |
| Trade receivables | 62.474 | 70.906 | 35.519 | 42.678 | Increase / (decrease) in share capital of subsidiaries | 0 | 370 | 0 | 0 |
| Other assets | 20.183 | 20.176 | 3.785 | 8.341 | Dividends of parent company | (958) | (958) | (958) | (958) |
| TOTAL ASSETS | 179.156 | 187.453 | 98.919 | 111.574 | Dividends paid to Minority Interests | 0 | (113) | 0 | 0 |
| Net gains and losses recognised directly in equity | 1.873 | 154 | 0 | 0 | |||||
| ΠΑΘΗΤΙΚΟ | Transfer to income statement due to sale | ||||||||
| Long-term liabilities | 24.753 | 16.469 | 603 | 2.614 | of available for sale financial assets | (1.192) | 0 | (1.192) | 0 |
| Short-term borrowings | 33.009 | 37.905 | 11.360 | 6.495 | Increase in the percentage of ownership in subsidiaries | 411 | 0 | 0 | 0 |
| Other current liabilities | 42.588 | 55.791 | 24.649 | 38.946 | (Purchases) / sales of treasury shares | 0 | (139) | 0 | (139) |
| Total liabilities ( a ) | 100.350 | 110.165 | 36.612 | 48.055 | Equity at the end of the period | ||||
| Share capital | 51.287 | 51.287 | 51.287 | 51.287 | (30.06.2007 and 30.06.2006 respectively) | 78.806 | 69.251 | 62.307 | 63.265 |
| Other accounts related to Shareholders´ Equity | 11.522 | 11.699 | 11.020 | 12.232 | |||||
| Total Shareholders´ Equity attributable to Shareholders of the Parent Company ( b ) | 62.809 | 62.986 | 62.307 | 63.519 | INCOME STATEMENT (consolidated and stand alone) amounts in thousand Euros | ||||
| Minority interests ( c ) | 15.997 | 14.302 | 0 | 0 | |||||
| Total Shareholders´ Equity ( d ) = ( b ) + ( c ) | 78.806 | 77.288 | 62.307 | 63.519 | GROUP | ||||
| TOTAL SHAREHOLDERS´ EQUITY AND LIABILITIES ( e ) = ( a ) + ( d ) | 179.156 | 187.453 | 98.919 | 111.574 | 01.01-30.06.2007 01.01-30.06.2006 01.04-30.06.2007 01.04-30.06.2006 | ||||
| Minority interests ( c ) | 15.997 | 14.302 | 0 | 0 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Shareholders´ Equity ( d ) = ( b ) + ( c ) | 78.806 | 77.288 | 62.307 | 63.519 | GROUP | |||||
| TOTAL SHAREHOLDERS´ EQUITY AND LIABILITIES ( e ) = ( a ) + ( d ) | 179.156 | 187.453 | 98.919 | 111.574 | 01.01-30.06.2007 01.01-30.06.2006 01.04-30.06.2007 01.04-30.06.2006 | |||||
| ADDITIONAL DATA AND INFORMATION | Sales | 109.393 | 95.415 | 48.640 | 42.528 | |||||
| Gross profit/(loss) | 22.820 | 19.097 | 10.548 | 8.846 | ||||||
| 1. Information regarding the companies which are consolidated in the above Financial Statements is presented in the following table: | Profit/(loss) before taxes, financing, investing | |||||||||
| activities & depreciation | 3.845 | 4.298 | 2.105 | 1.905 | ||||||
| Profit/(loss) before taxes, financing | ||||||||||
| Company | Country of | Participation | Consolidation | Consolidation | Unaudited | & investing activities | 2.199 | 2.858 | 1.268 | 1.188 |
| Registered Office | Percentage | Relation | Method | fiscal years | Profit/(loss) before taxes | 1.852 | 1.715 | 1.654 | 565 | |
| ELGEKA A.E. | GREECE | PARENT | - | - | 2005-2006 | Less: taxes | 468 | 254 | 448 | 64 |
| LOGISTICS SERVICES HELLAS A.E. | GREECE | 99,99% | DIRECT | FULL CONSOLID. | 2003-2006 | Profit/(loss) after taxes from continuing operations | 1.384 | 1.461 | 1.206 | 501 |
| PAPADIMITRIOY X.K. A.E. | GREECE | 50% + 1 Share | DIRECT | FULL CONSOLID. | 2003-2006 | Distributed to : | ||||
| ΒΙΟΤΡΟΣ Α.Β.Ε.Ε. | GREECE | 80,00% | DIRECT | FULL CONSOLID. | 2005-2006 | Company's shareholders | 1.048 | 1.130 | 625 | 306 |
| HERO HELLAS A.E. (ex SAMBROOK A.E.) ( 1 ) | GREECE | 30,00% | DIRECT | EQUITY METHOD | 2002-2006 | Minority interests | 336 | 331 | 581 | 195 |
| SAMBROOK PHARMACEUTICAL A.E. ( 2 ) | GREECE | 45,00% | INDIRECT | FULL CONSOLID. | 2003-2006 | Earnings per share (after taxes) - basic (in Euro) | 0,03 | 0,04 | 0,02 | 0,01 |
| Profit/(loss) before taxes, financing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Company | Country of | Participation | Consolidation | Consolidation | Unaudited | & investing activities | 2.199 | 2.858 | |
| Registered Office | Percentage | Relation | Method | fiscal years | Profit/(loss) before taxes | 1.852 | 1.715 | ||
| ELGEKA A.E. | GREECE | PARENT | - | - | 2005-2006 | Less: taxes | 468 | 254 | |
| LOGISTICS SERVICES HELLAS A.E. | GREECE | 99,99% | DIRECT | FULL CONSOLID. | 2003-2006 | Profit/(loss) after taxes from continuing operations | 1.384 | 1.461 | |
| PAPADIMITRIOY X.K. A.E. | GREECE | 50% + 1 Share | DIRECT | FULL CONSOLID. | 2003-2006 | Distributed to : | |||
| ΒΙΟΤΡΟΣ Α.Β.Ε.Ε. | GREECE | 80,00% | DIRECT | FULL CONSOLID. | 2005-2006 | Company's shareholders | 1.048 | 1.130 | |
| HERO HELLAS A.E. (ex SAMBROOK A.E.) ( 1 ) | GREECE | 30,00% | DIRECT | EQUITY METHOD | 2002-2006 | Minority interests | 336 | 331 | |
| SAMBROOK PHARMACEUTICAL A.E. ( 2 ) | GREECE | 45,00% | INDIRECT | FULL CONSOLID. | 2003-2006 | Earnings per share (after taxes) - basic (in Euro) | 0,03 | 0,04 | |
| MEDIHELM PHARMAC.WHOLESALE STORE A.E. ( 3 ) | GREECE | 51,00% | DIRECT | FULL CONSOLID. | 2005-2006 | ||||
| SAMBROOK PHARMA PHARMACEUTICAL LTD ( 4 ) | GREECE | 51,00% | DIRECT | FULL CONSOLID. | 1st acc. Period | INCOME STATEMENT (consolidated and stand alone) amounts in thousand Euros | |||
| ELGEKA (CYPRUS) LTD | CYPRUS | 100,00% | DIRECT | FULL CONSOLID. | 2001-2006 | ||||
| ELGEKA FERFELIS ROMANIA SRL | ROMANIA | 52,63% | INDIRECT | FULL CONSOLID. | 2004-2006 | COMPANY | |||
| ELGEKA FERFELIS BULGARIA LTD ( 5 ) | BULGARIA | 39,47% | INDIRECT | FULL CONSOLID. | 2006 | 01.01-30.06.2007 01.01-30.06.2006 01.04-30.06.2007 01.04-30.06.2006 | |||
| ELGEKA FERFELIS SRL ( 6 ) | MOLDAVA | 52,63% | INDIRECT | FULL CONSOLID. | 1st acc. Period | ||||
| CERA VILLA DESIGN SRL | ROMANIA | 36,84% | INDIRECT | FULL CONSOLID. | 2005-2006 | Sales | 54.312 | 43.405 | |
| HODDLE HOLDINGS LTD (7) | CYPRUS | 100,00% | INDIRECT | FULL CONSOLID. | 1999-2006 | Gross profit/(loss) | 12.841 | 9.613 | |
| GATEDOOR HOLDINGS LTD | CYPRUS | 50,00% | INDIRECT | FULL CONSOLID. | 2003-2006 | Profit/(loss) before taxes, financing, investing | |||
| SC GATEDOOR HOLDINGS COM SRL | ROMANIA | 50,01% | INDIRECT | FULL CONSOLID. | 2005-2006 | activities & depreciation | 829 | 1.446 | |
| GREC-ROM BUSINESS GROUP SRL ( 8 ) | ROMANIA | 25,00% | INDIRECT | PROPORT. METHOD | 2004-2006 | Profit/(loss) before taxes, financing | |||
| MEDIZONE GERMANY GMBH | GERMANY | 27,50% | INDIRECT | EQUITY METHOD | 2004-2006 | & investing activities | 225 | 857 |
| ELGEKA (CYPRUS) LTD | CYPRUS | 100,00% | DIRECT | FULL CONSOLID. | 2001-2006 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| ELGEKA FERFELIS ROMANIA SRL | ROMANIA | 52,63% | INDIRECT | FULL CONSOLID. | 2004-2006 | COMPANY | ||||
| ELGEKA FERFELIS BULGARIA LTD ( 5 ) | BULGARIA | 39,47% | INDIRECT | FULL CONSOLID. | 2006 | 01.01-30.06.2007 01.01-30.06.2006 01.04-30.06.2007 01.04-30.06.2006 | ||||
| ELGEKA FERFELIS SRL ( 6 ) | MOLDAVA | 52,63% | INDIRECT | FULL CONSOLID. | 1st acc. Period | |||||
| CERA VILLA DESIGN SRL | ROMANIA | 36,84% | INDIRECT | FULL CONSOLID. | 2005-2006 | Sales | 54.312 | 43.405 | 20.691 | 15.534 |
| HODDLE HOLDINGS LTD (7) | CYPRUS | 100,00% | INDIRECT | FULL CONSOLID. | 1999-2006 | Gross profit/(loss) | 12.841 | 9.613 | 5.734 | 3.896 |
| GATEDOOR HOLDINGS LTD | CYPRUS | 50,00% | INDIRECT | FULL CONSOLID. | 2003-2006 | Profit/(loss) before taxes, financing, investing | ||||
| SC GATEDOOR HOLDINGS COM SRL | ROMANIA | 50,01% | INDIRECT | FULL CONSOLID. | 2005-2006 | activities & depreciation | 829 | 1.446 | (77) | 476 |
| GREC-ROM BUSINESS GROUP SRL ( 8 ) | ROMANIA | 25,00% | INDIRECT | PROPORT. METHOD | 2004-2006 | Profit/(loss) before taxes, financing | ||||
| MEDIZONE GERMANY GMBH | GERMANY | 27,50% | INDIRECT | EQUITY METHOD | 2004-2006 | & investing activities | 225 | 857 | (380) | 180 |
| Profit/(loss) before taxes | 1.174 | 736 | 718 | 285 | ||||||
| (1) HERO HELLAS A.E. was included in the current period Consolidated Financial Statements using the equity method, unlike the comparative period of 2006 when it has been fully consolidated. The | Less: taxes | 236 | 87 | 169 | 11 | |||||
| rationale for this change in the consolidation method is the sale of 21% of its ownership to HERO HELLAS A.E. decreasing its participation to the share capital from 51% to 30%. | Profit/(loss) after taxes from continuing operations | 938 | 649 | 549 | 274 | |||||
| (2) SAMBROOK PHARMACEUTICAL S.A. was included in the current period Consolidated Financial Statements using the full consolidation method, because the Parent company ELGEKA S.A. participates directly in its share capital by 45% and the Group controls the majority of the voting rights due to an agreement with one of the shareholders. In the comparative period of 2006, ELGEKA |
Earnings per share (after taxes) - basic (in Euro) | 0,03 | 0,02 | 0,02 | 0,01 | |||||
CASHFLOW (consolidated and stand alone) amounts in thousand Euros
| INDIRECT METHOD | GROUP | COMPANY | ||
|---|---|---|---|---|
| 01.01-30.06.2007 01.01-30.06.2006 01.01-30.06.2007 01.01-30.06.2006 | ||||
| Operating activities | ||||
| Profit before taxes | 1.852 | 1.715 | 1.174 | 736 |
| Add/less adjustments for: | ||||
| Depreciation | 1.646 | 1.440 | 604 | 589 |
| Provisions | 1.331 | 320 | 547 | 157 |
| Exchange differences | 366 | 39 | 0 | 1 |
| Amortisation of grants | (63) | (63) | 0 | 0 |
| (Profit) / Loss on sale - destruction of assets | 341 | 57 | (7) | (9) |
| Results (income, expense, gains & loss) of investing activities | (1.202) | (214) | (1.275) | (295) |
| Interest expense & similar charges | 1.537 | 1.357 | 314 | 416 |
| Changes in working capital | ||||
| Decrease / (increase) in inventories | 940 | 1.634 | 2.440 | 2.221 |
| Decrease / (increase) in receivables | 8.745 | 12.537 | 10.167 | 14.550 |
| (Decrease) / increase in payables (except banks) | (14.592) | (19.197) | (15.443) | (17.340) |
| Less: | ||||
| Interest expense & similar charges paid | (1.583) | (1.467) | (360) | (447) |
| Income taxes paid | (348) | (438) | (95) | (76) |
| Total inflow / (outflow) from | ||||
| operating activities ( a ) | (1.030) | (2.280) | (1.934) | 503 |
| Investing activities | ||||
| Increase in share capital of subsidiaries / acquisition of associates | 0 | (1) | (3.828) | (250) |
| Advances paid due to share capital increase of subsidiaries | (2.200) | 0 | 0 | 0 |
| Proceeds from sale of subsidiaries and associates | 180 | 9.500 | 0 | 9.500 |
| Proceeds from sale of securities | 2.667 | 0 | 2.667 | 0 |
| Acquisition / increase in share capital of | ||||
| available for sale financial assets | 0 | (95) | 0 | (95) |
| Return / decrease in share capital of | ||||
| available for sale financial assets Purchase of tangible and intangible assets |
0 (3.118) |
277 (1.957) |
0 (929) |
277 (393) |
| Proceeds from sales of tangible and intangible assets | 126 | 151 | 26 | 33 |
| Purchase of investment property | (1.558) | (374) | 0 | 0 |
| Proceeds from sale of investment property | 73 | 44 | 0 | 0 |
| Proceeds from grants of tangible assets | 0 | 308 | 0 | 0 |
| Interest received | 80 | 36 | 9 | 14 |
| Total inflow / (outflow) from Investing activities ( b ) |
(3.750) | 7.889 | (2.055) | 9.086 |
| Financing activities | ||||
| Proceeds from minority interests (increase in share capital) | 411 | 370 | 0 | 0 |
| (Purchases) / sales of treasury shares Proceeds from loans |
0 64.352 |
(139) 14.164 |
0 14.850 |
(139) 5.000 |
| Repayment of loans | (61.442) | (15.587) | (11.950) | (10.270) |
| Payment of leasing liabilities | 31 | (30) | 0 | 0 |
| Dividends paid to Company's Shareholders | 0 | (7) | (1) | (7) |
| Dividends paid to Minority Interests | 0 | (113) | 0 | 0 |
| Total inflow / (outflow) from | ||||
| Financing activities ( c ) | 3.352 | (1.342) | 2.899 | (5.416) |
| Net increase / (decrease) in cash and cash equivalents ( a ) + ( b ) + ( c ) |
(1.428) | 4.267 | (1.090) | 4.173 |
| Cash and cash equivalents at the beginning of the year | 6.801 | 5.354 | 1.827 | 1.078 |
| Cash and cash equivalents at the end of the year | 5.373 | 9.621 | 737 | 5.251 |
Translation Note: A Greek "anonymos eteria" (AE) is broadly similar to a French "societe anonyme" or a German "Aktiengesellschaft" and a Greek "omorythmi eteria" (OE) is broadly similar to a French "societe en nom collectif" or a German "offene Handelsgesellschaft".
CHAIRMAN OF THE B. OF D. DEPUTY MANAGING DIRECTOR ACCOUNTING DPT. SUPERVISOR
AND MANAGING DIRECTOR & FINANCE DIRECTOR
ALEXANDROS KATSIOTIS PARIS TOKTOKOGLOU KONSTANTINOS MEINTANIS
ID.No. X 232184/01 ID No : ΑΕ 180557 / 07 Tax Reg.No: 030961080 Tax Auth.:Z' THESSALONIKIS Acc.Reg.No:0017678 Class: A'
The financial data and information presented below provide a general overview of the financial position and results of the Group and ELGEKA A.E. Trade - Distributions - Representations - Industry. Therefore, it is recommemded to any reader, before proceeeding to any investment decision or other transaction with the company, to visit the company's website (www.elgeka.gr) where the Interim Financial Statements prepared in accordance with the International Financial Reporting Standards, are published, together with the review report of certified auditors - accountants whenever is required
Website: www.elgeka.gr Date of approval of the Interim Financial Statements of the 1st half : 30 August 2007
(2) SAMBROOK PHARMACEUTICAL S.A. was included in the current period Consolidated Financial Statements using the full consolidation method, because the Parent company ELGEKA S.A. participates directly in its share capital by 45% and the Group controls the majority of the voting rights due to an agreement with one of the shareholders. In the comparative period of 2006, ELGEKA S.A. participated indirectly (through HERO HELLAS S.A.) to SAMBROOK PHARMACEUTICAL S.A. (ex SAMBROOK & SIA O.E.) by 25,50% and had been fully consolidated by the exact share. (see note 1 Interim Financial Statements - Other Information).
(3) MEDIHELM PHARMAC.WHOLESALE STORE A.E. has been fully consolidated in the current period with the percentage of 51% (direct) while in the comparative period of 2006 it has been consolidated with the percentage of 50,49% (indirect). The reason for this change is that on September 28, 2006 the Parent Company acquired the 51% of MEDIHELM PHARMAC.WHOLESALE STORE A.E. from HERO HELLAS A.E. which owned the 99%.
(4) SAMBROOK PHARMA PHARMACEUTICALS LTD, which was established in October 2006, has been included in the Consolidated Financial Statements for the current period 01/01 – 30/06/2007 and has not been included in the comparative period. The company's figures considered as not important for the Group.
(5) ELGEKA FERFELIS BULGARIA LTD, which was established in July 2006, has been included in the Consolidated Financial Statements for the current period 01/01 – 30/06/2007 and has not been included in the comparative period. "ELGEKA FERFELIS ROMANIA SRL" participates in the aforementioned company by 75%. It should also be mentioned that the company's figures considered as not important in the consolidated results.
(6) On March 19, 2007 ELGEKA FERFELIS ROMANIA SRL established "ELGEKA FERFELIS SRL" located in Chisinau, Moldova whose operation will mainly be commercial including imports and exports of goods and services and commercial representation.
(7) HOODLE HOLDINGS LTD, is in the process of voluntary liquidation. The company's figures considered as not important for the Group and as a result no adjustments are required to be performed. (8) GREC ROM BUSINESS GROUP SRL has been consolidated using the proportionate method in the current period 01/01 – 30/06/2007 unlike the comparative period of 2006 when it has been fully consolidated. The rationale for this change in the consolidation method is that the Group no longer possesses the majority of the votes of the company while its share remains the same.
NOTES: a) PALIRRIA – SOULIOTIS S.A. has not been included in the Consolidated Financial Statements for the period 01/01 – 30/06/2007, unlike the comparative period of 2006, using the equity method, due to the disposal of the total share of 20% that the Parent Company possessed on December 20, 2006. In the Consolidated figures of the corresponding period in 2006 there is a total amount of euro 164 thousand concerning "Gains/(losses) from affiliated companies" from which an amount of euro 162 thousand concerned the results of PALIRRIA – SOULIOTIS S.A for that period. b) ONIA – NET S.A. was included in the Consolidated Financial Statements for the period 01/01 – 30/06/2006, unlike the current period due to its write – off on May 08, 2006 following the respective court decision (the aforementioned company had terminated its operation since 2003 and it was in a dormant state thereafter). The Company's figures considered as not significant for the Group, while in the Consolidated Financial Statements was fully impaired. c) NETWORK MARKETING SRL which was consolidated using the equity method has not been included in the Consolidated Financial Statements for the period 01/01 – 30/06/2007, unlike the comparative period of 2006, due to the completion of its liquidation process on June 26, 2006. The Company's figures considered as insignificant for the Group, and it was fully impaired. d) HIGHWAY TRADING SRL (subsidiary of ELGEKA S.A. with indirect participation of 100%, fully consolidated) has been absorbed by S.C. GATEDOOR HOLGINGS SRL on November 21, 2006. The book and fair values applied were the same with those on March 31, 2006. e) EVEREST FRANCHISING SRL together with both its subsidiariesEVEREST FOODS SRL and EVEREST PRODUCTION SRL has been included in the Consolidated Financial Statements for the period 01/01 – 30/06/2006 using the equity method, unlike the current period, because ELGEKA (CYPRUS) LTD disposed its share of 49,22% in the EVEREST FRANCHISING SRL and consequently in its subsidiaries (99,98% and 98,00% share in EVEREST FOODS SRL and EVEREST PRODUCTION SRL respectively) during the first quarter 2007. The gain on the above disposal amounted to euro 30 thousand. The figures of the above companies considered as insignificant for the Group.
| 2. The accounting principles applied are the same with the ones applied for the preparation of the annual Financial Statements for the year ended on | ||||
|---|---|---|---|---|
| -- | ------------------------------------------------------------------------------------------------------------------------------------------------------ | -- | -- | -- |
December 31, 2006. 3. There are no encumbrances on the fixed assets of the Parent Company, while there are mortgages on the buildings of subsidiaries amounting to euro 11.607 thousand as security for loans.
4. There is no pending litigation that could materially affect the financial position of the Company and the Group. 5. The number of employees of the Group as at 30/06/2007 is 1.259 and of the Company is 237 (30/06/06 Group 1.106 and Company 250 respectively).
6. Sales and purchases (of goods and services) aggregated from the beginning of the period as well as receivable and payable balances of the parent Company and the Group in the end of the current period, created from transactions with related companies, as these are defined in IAS 24, are given below:
| GROUP | COMPANY | ||
|---|---|---|---|
| a) Sales of goods and services | 1 | 55 | |
| b) Purchases of goods and services | 168 | 455 | |
| c) Receivables | 140 | 146 | |
| d) Payables | 34 | 40 | |
| e) Key management personnel and members of the board compensation | 456 | 456 | |
| f) Receivables from key management personnel and members of the board | - | - | |
| g) Payables to key management personnel and members of the board | - | - |
| . | |||
|---|---|---|---|
The cost of this investment was euro 44 million. A part of the total cost was covered by share capital increase of euro 7.050 thousand in cash and the issue of 235.000 new shares decided by the company L.S.H. A.E. on June 1st 2007, in which ELGEKA A.E. participated with its existing portion of 99,99%. The remaining part was funded by bank loan of euro 37 million received by L.S.H. The loan is due within 18 months and it is guaranteed by ELGEKA A.E., while for securing the loan the bank has pledged the 100% shares of the company DIAKINISIS A.E. till the date of its merger with the company L.S.H. Until June 30, 2007 the acquisition was still pending of the approval of the Competition Commission. On July 19, 2007 the Competition Commission with
its decision 349/V/2007 approved the acquisition of the company DIAKINISIS A.E. from L.S.H A.E. and on July 25, 2007 the transfer of shares, the payment and the sign off the transaction were completed and the Group acquired the total control of the entity.
Furthermore, the Board of Directors of L.S.H. and DIAKINISIS A.E. decided the merger of the two companies and specifically, the first one to be absorbed by the second one under the of Codified Law 2190/1920 (articles 66-77) and the combination of the Law 2166/1993 (articles 1-5) with the transition date of L.S.H as of June 30, 2007.
The Merger Contract was approved by both parties management on August 7, 2007 can be found in the web site of ELGEKA A.E. in the address www.elgeka.gr.
The merger has not been approved by the General Meetings of the shareholders of the two companies yet, as well as by the relative local authorities as these defined by the law and is estimated to be finalised till the end of October 2008. (For more information see note 23 Interim Financial Statements – Post Balance-Sheet events).
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.